Destruction of Hazardous Imports Act
Download PDFSponsored by
Rep. Higgins, Clay [R-LA-3]
ID: H001077
Bill's Journey to Becoming a Law
Track this bill's progress through the legislative process
Latest Action
Placed on the Union Calendar, Calendar No. 613.
June 17, 2026
Introduced
📍 Current Status
Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.
Committee Review
Floor Action
Passed House
Senate Review
Passed Congress
Presidential Action
Became Law
📚 How does a bill become a law?
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Bill Summary
Another masterpiece of legislative theater, courtesy of the 119th Congress. Let's dissect this farce, shall we?
**Main Purpose & Objectives:** The Destruction of Hazardous Imports Act (HR 2715) claims to extend the Secretary of Health and Human Services' authority to destroy articles that pose a significant public health concern. How noble. In reality, this bill is a Band-Aid on a bullet wound, designed to appease the masses while serving the interests of pharmaceutical lobbyists and bureaucratic empire-builders.
**Key Provisions & Changes to Existing Law:** The bill amends the Federal Food, Drug, and Cosmetic Act to grant the Secretary of Health and Human Services the power to order the destruction of refused articles that present a significant public health concern. Because, you know, the current system of simply refusing admission wasn't enough; now we need to destroy the evidence. The bill also introduces new regulations, because what's a legislative act without more red tape?
**Affected Parties & Stakeholders:** The usual suspects: pharmaceutical companies, importers, exporters, and the Secretary of Health and Human Services. Oh, and let's not forget the taxpayers, who will foot the bill for this bureaucratic boondoggle.
**Potential Impact & Implications:** This bill is a classic case of "legislative placebo effect." It promises to address public health concerns but will likely only serve to further entrench the interests of powerful lobbies. The destruction of hazardous imports will be a drop in the ocean compared to the real issues plaguing our healthcare system. Meanwhile, the added regulations and bureaucratic hurdles will strangle small businesses and innovation, because who needs competition when you have crony capitalism?
In conclusion, HR 2715 is a textbook example of legislative malpractice. It's a symptom of a deeper disease: the corruption, cowardice, and stupidity that plague our political system. The real diagnosis? A bad case of " Politicus Egotisticalus," where self-serving politicians prioritize their own interests over the well-being of the people they're supposed to serve. Now, if you'll excuse me, I have better things to do than watch this train wreck unfold.
Related Topics
💰 Campaign Finance Network
Rep. Higgins, Clay [R-LA-3]
Congress 119 • 2024 Election Cycle
No PAC contributions found
No organization contributions found
No committee contributions found
Cosponsors & Their Campaign Finance
This bill has 10 cosponsors. Below are their top campaign contributors.
Rep. Carter, Troy A. [D-LA-2]
ID: C001125
Top Contributors
10
Rep. Weber, Randy K. Sr. [R-TX-14]
ID: W000814
Top Contributors
10
Rep. Nehls, Troy E. [R-TX-22]
ID: N000026
Top Contributors
10
Rep. Letlow, Julia [R-LA-5]
ID: L000595
Top Contributors
10
Rep. Murphy, Gregory F. [R-NC-3]
ID: M001210
Top Contributors
10
Rep. Steube, W. Gregory [R-FL-17]
ID: S001214
Top Contributors
10
Rep. Haridopolos, Mike [R-FL-8]
ID: H001099
Top Contributors
10
Rep. Ezell, Mike [R-MS-4]
ID: E000235
Top Contributors
10
Rep. Bilirakis, Gus M. [R-FL-12]
ID: B001257
Top Contributors
10
Rep. Kiggans, Jennifer A. [R-VA-2]
ID: K000399
Top Contributors
10
Donor Network - Rep. Higgins, Clay [R-LA-3]
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 33 nodes and 35 connections
Total contributions: $126,300
Top Donors - Rep. Higgins, Clay [R-LA-3]
Showing top 16 donors by contribution amount
Industry Impact
Which industries are materially affected by specific provisions in this bill. 3 harmed.
- −Pharmaceuticals confidence 0.90
Section 2(a)(2) amends the FD&C Act to replace 'drug or device' with 'drug, device, or other article' in the destruction authority, expanding HHS's power to destroy refused articles that present a significant public health concern. This could lead to increased regulatory scrutiny and potential destruction of pharmaceutical imports, imposing costs on the pharmaceutical industry.
- −Medical Devices confidence 0.90
Same amendment as above includes 'device' in the expanded destruction authority, allowing HHS to destroy refused medical devices deemed a public health concern, which could increase compliance costs and risk of product loss for medical device manufacturers.
- −Biotech & Research confidence 0.80
Biotech products (e.g., biologics, gene therapies) fall under the FD&C Act's definition of 'drug' or 'other article.' The expanded destruction authority could apply to biotech imports, creating regulatory risk and potential financial impact.